Chronic myelomonocytic leukemia with central nervous system involvement

Leuk Lymphoma. 2018 Sep;59(9):2267-2268. doi: 10.1080/10428194.2017.1422866. Epub 2018 Jan 11.

Authors

Michelle Hannon¹, Lindsay Wilde², Nneamaka Nwaoduah³, Margaret Kasner²

Affiliations

¹ a Sidney Kimmel Medical College at Thomas Jefferson University , Philadelphia , PA , USA.
² b Sidney Kimmel Cancer Center of Thomas Jefferson University Hospital , Philadelphia , PA , USA.
³ c Department of Pathology , Thomas Jefferson University Hospital , Philadelphia , PA , USA.

PMID: 29322838
DOI: 10.1080/10428194.2017.1422866

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antimetabolites, Antineoplastic / therapeutic use
Central Nervous System / pathology*
Cytarabine / therapeutic use
Hematopoietic Stem Cell Transplantation / methods
Humans
Leukemia, Myelomonocytic, Chronic / blood
Leukemia, Myelomonocytic, Chronic / cerebrospinal fluid
Leukemia, Myelomonocytic, Chronic / therapy*
Leukocytosis / blood
Leukocytosis / cerebrospinal fluid
Male
Methotrexate / therapeutic use
Middle Aged
Monocytes / pathology
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Cytarabine
Methotrexate